Latest Insider Transactions at Haemonetics Corp (HAE)
This section provides a real-time view of insider transactions for Haemonetics Corp (HAE). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of HAEMONETICS CORP to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of HAEMONETICS CORP's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 01
2024
|
Roy Galvin President, Global Plasma & BC |
SELL
Payment of exercise price or tax liability
|
Direct |
161
-2.14%
|
$11,431
$71.48 P/Share
|
|
Sep 17
2024
|
Laurie A. Miller SVP, Human Resources |
SELL
Payment of exercise price or tax liability
|
Direct |
238
-1.32%
|
$18,088
$76.54 P/Share
|
|
Aug 29
2024
|
Simon, Christopher President & CEO |
SELL
Other acquisition or disposition
|
Direct |
39,704
-10.95%
|
$2,977,800
$75.56 P/Share
|
|
Jul 26
2024
|
Stewart W Strong President, Global Hospital |
SELL
Open market or private sale
|
Direct |
4,312
-19.16%
|
$392,392
$91.15 P/Share
|
|
Jul 25
2024
|
Stewart W Strong President, Global Hospital |
SELL
Payment of exercise price or tax liability
|
Direct |
2,798
-11.06%
|
$251,820
$90.58 P/Share
|
|
Jul 25
2024
|
Diane M Bryant Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,207
+33.24%
|
-
|
|
Jul 25
2024
|
Robert E Abernathy Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,207
+9.01%
|
-
|
|
Jul 25
2024
|
Mark W Kroll Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,207
+9.65%
|
-
|
|
Jul 25
2024
|
Lloyd Emerson Johnson Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,207
+17.73%
|
-
|
|
Jul 25
2024
|
Charles J Dockendorff Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,207
+33.24%
|
-
|
|
Jul 25
2024
|
Michael J Coyle Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,207
+14.8%
|
-
|
|
Jul 25
2024
|
Ellen M Zane Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,207
+11.69%
|
-
|
|
Jul 25
2024
|
Claire Pomeroy Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,207
+13.47%
|
-
|
|
Jul 24
2024
|
Stewart W Strong President, Global Hospital |
BUY
Grant, award, or other acquisition
|
Direct |
7,110
+21.93%
|
-
|
|
Jul 12
2024
|
Anila Lingamneni EVP, Chief Technology Officer |
SELL
Open market or private sale
|
Direct |
79
-0.37%
|
$7,110
$90.0 P/Share
|
|
Jul 11
2024
|
Anila Lingamneni EVP, Chief Technology Officer |
SELL
Open market or private sale
|
Direct |
2,136
-9.07%
|
$192,240
$90.0 P/Share
|
|
Jun 06
2024
|
Simon, Christopher President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
71,335
-16.44%
|
$6,206,145
$87.38 P/Share
|
|
Jun 06
2024
|
Simon, Christopher President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
104,516
+19.41%
|
$4,285,156
$41.64 P/Share
|
|
May 29
2024
|
Michelle L Basil EVP and General Counsel |
SELL
Open market or private sale
|
Direct |
12,990
-15.84%
|
$1,143,120
$88.22 P/Share
|
|
May 29
2024
|
Stewart W Strong President, Global Hospital |
SELL
Open market or private sale
|
Direct |
8,857
-32.74%
|
$770,559
$87.53 P/Share
|
|
May 28
2024
|
Anila Lingamneni EVP, Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,279
-18.31%
|
$501,505
$95.73 P/Share
|
|
May 28
2024
|
Anila Lingamneni EVP, Chief Technology Officer |
BUY
Grant, award, or other acquisition
|
Direct |
14,140
+32.91%
|
-
|
|
May 28
2024
|
Josep Llorens EVP, Global Manufacturing |
SELL
Payment of exercise price or tax liability
|
Direct |
4,510
-12.72%
|
$428,450
$95.73 P/Share
|
|
May 28
2024
|
Josep Llorens EVP, Global Manufacturing |
BUY
Grant, award, or other acquisition
|
Direct |
14,140
+28.51%
|
-
|
|
May 28
2024
|
Laurie A. Miller SVP, Human Resources |
SELL
Payment of exercise price or tax liability
|
Direct |
778
-4.13%
|
$73,910
$95.73 P/Share
|
|
May 28
2024
|
Laurie A. Miller SVP, Human Resources |
BUY
Grant, award, or other acquisition
|
Direct |
2,650
+12.34%
|
-
|
|
May 28
2024
|
Michelle L Basil EVP and General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
11,758
-20.99%
|
$1,117,010
$95.73 P/Share
|
|
May 28
2024
|
Michelle L Basil EVP and General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
24,748
+30.65%
|
-
|
|
May 28
2024
|
Simon, Christopher President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
41,736
-11.25%
|
$3,964,920
$95.73 P/Share
|
|
May 28
2024
|
Simon, Christopher President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
106,062
+22.23%
|
-
|
|
May 28
2024
|
Stewart W Strong President, Global Hospital |
SELL
Payment of exercise price or tax liability
|
Direct |
4,399
-13.99%
|
$417,905
$95.73 P/Share
|
|
May 28
2024
|
Stewart W Strong President, Global Hospital |
BUY
Grant, award, or other acquisition
|
Direct |
13,256
+29.65%
|
-
|
|
May 20
2024
|
Stewart W Strong President, Global Hospital |
SELL
Open market or private sale
|
Direct |
686
-3.63%
|
$65,170
$95.11 P/Share
|
|
May 20
2024
|
Stewart W Strong President, Global Hospital |
SELL
Payment of exercise price or tax liability
|
Direct |
1,555
-7.61%
|
$147,725
$95.08 P/Share
|
|
May 20
2024
|
Stewart W Strong President, Global Hospital |
BUY
Exercise of conversion of derivative security
|
Direct |
2,241
+9.88%
|
$125,496
$56.57 P/Share
|
|
May 20
2024
|
Josep Llorens EVP, Global Manufacturing |
SELL
Open market or private sale
|
Direct |
987
-4.43%
|
$93,765
$95.08 P/Share
|
|
May 20
2024
|
Michelle L Basil EVP and General Counsel |
SELL
Open market or private sale
|
Direct |
1,604
-4.88%
|
$152,380
$95.08 P/Share
|
|
May 17
2024
|
Farris Maryanne Maunsell VP, Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
587
+33.91%
|
-
|
|
May 17
2024
|
Stewart W Strong President, Global Hospital |
BUY
Grant, award, or other acquisition
|
Direct |
2,872
+13.63%
|
-
|
|
May 17
2024
|
Stewart W Strong President, Global Hospital |
SELL
Payment of exercise price or tax liability
|
Direct |
284
-1.82%
|
$26,980
$95.73 P/Share
|
|
May 17
2024
|
Anila Lingamneni EVP, Chief Technology Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,394
+18.77%
|
-
|
|
May 17
2024
|
Anila Lingamneni EVP, Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
349
-3.0%
|
$33,155
$95.73 P/Share
|
|
May 17
2024
|
Laurie A. Miller SVP, Human Resources |
BUY
Grant, award, or other acquisition
|
Direct |
2,089
+11.44%
|
-
|
|
May 17
2024
|
Laurie A. Miller SVP, Human Resources |
SELL
Payment of exercise price or tax liability
|
Direct |
76
-0.54%
|
$7,220
$95.73 P/Share
|
|
May 17
2024
|
Roy Galvin President, Global Plasma & BC |
BUY
Grant, award, or other acquisition
|
Direct |
2,872
+27.93%
|
-
|
|
May 17
2024
|
Josep Llorens EVP, Global Manufacturing |
BUY
Grant, award, or other acquisition
|
Direct |
6,267
+21.94%
|
-
|
|
May 17
2024
|
Josep Llorens EVP, Global Manufacturing |
SELL
Payment of exercise price or tax liability
|
Direct |
320
-1.96%
|
$30,400
$95.73 P/Share
|
|
May 17
2024
|
Josep Llorens EVP, Global Manufacturing |
SELL
Open market or private sale
|
Direct |
822
-4.79%
|
$77,268
$94.82 P/Share
|
|
May 17
2024
|
Michelle L Basil EVP and General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
4,178
+11.28%
|
-
|
|
May 17
2024
|
Michelle L Basil EVP and General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
669
-2.28%
|
$63,555
$95.73 P/Share
|